Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seojeong Kim

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
European Journal of Medicinal Chemistry|October 22, 2021
Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitorsSoo-Yeon Hwang, Aarajana Shrestha, Seojeong Park, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 16, 2025
Cannabigerol attenuates liver fibrosis via AMPK activation: Regulation of lipid metabolism, inflammation, and hepatic stellate cell activationKyung-Hwa Jeon, Seojeong Kim, Seojeong Park, et al.
Journal of Advanced Research|August 13, 2022
Interrupting specific hydrogen bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancersSoo-Yeon Hwang, Seojeong Park, Hyunji Jo, et al.
Molecular Cancer|May 9, 2025
Targeting the HER2-ELF3-KRAS axis: a novel therapeutic strategy for KRAS<sup>G13D</sup> colorectal cancerSoo-Yeon Hwang, Yoojeong Seo, Seojeong Park, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
European Journal of Medicinal Chemistry|October 22, 2021
Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitorsSoo-Yeon Hwang, Aarajana Shrestha, Seojeong Park, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 16, 2025
Cannabigerol attenuates liver fibrosis via AMPK activation: Regulation of lipid metabolism, inflammation, and hepatic stellate cell activationKyung-Hwa Jeon, Seojeong Kim, Seojeong Park, et al.
Journal of Advanced Research|August 13, 2022
Interrupting specific hydrogen bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancersSoo-Yeon Hwang, Seojeong Park, Hyunji Jo, et al.
Molecular Cancer|May 9, 2025
Targeting the HER2-ELF3-KRAS axis: a novel therapeutic strategy for KRAS<sup>G13D</sup> colorectal cancerSoo-Yeon Hwang, Yoojeong Seo, Seojeong Park, et al.
Pageof 2